IL-1β increases inflammatory signaling and enhances epithelial-mesenchymal transition in cancer cells through the IL-1β/HIF-1α/COX2 axis, which promotes the invasive capacities of tumoral cells in a hypoxic microenvironment. Here, HIF1A is linked to cancer.